Mastall M, Roth P, Bink A, Fischer Maranta A, et al. A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC Cancer 2024;24:82.
PMID: 38225589